Related references
Note: Only part of the references are listed.Comprehensive genomic profiling of Brazilian non-small cell lung cancer patients (GBOT 0118/LACOG0418)
Eldsamira Mascarenhas et al.
THORACIC CANCER (2021)
Prevalence of the Brazilian TP53 Founder c.1010G>A (p.Arg337His) in Lung Adenocarcinoma: Is Genotyping Warranted in All Brazilian Patients?
Igor Araujo Vieira et al.
FRONTIERS IN GENETICS (2021)
Mutant p53 in cell-cell interactions
Steven Pilley et al.
GENES & DEVELOPMENT (2021)
Precision oncology: Directing genomics and pharmacogenomics toward reducing cancer inequities
Loren Saulsberry et al.
CANCER CELL (2021)
Identification of the TP53 p.R337H Variant in Tumor Genomic Profiling Should Prompt Consideration of Germline Testing for Li-Fraumeni Syndrome
Renata Lazari Sandoval et al.
JCO GLOBAL ONCOLOGY (2021)
High Prevalence of EGFR Mutations in Lung Adenocarcinomas From Brazilian Patients Harboring the TP53 p.R337H Variant
Malu Viter R. Barbosa et al.
CLINICAL LUNG CANCER (2020)
Genomic landscape of lung adenocarcinoma in East Asians
Jianbin Chen et al.
NATURE GENETICS (2020)
Mutational Profiling of Driver Tumor Suppressor and Oncogenic Genes in Brazilian Malignant Pleural Mesotheliomas
Nathalia C. Campanella et al.
PATHOBIOLOGY (2020)
Prognostic value of KRAS/TP53/PIK3CA in non-small cell lung cancer
Jiayi Zhao et al.
ONCOLOGY LETTERS (2019)
Expression of p16 and p53 in non-small-cell lung cancer: clinicopathological correlation and potential prognostic impact
Yangying Zhou et al.
BIOMARKERS IN MEDICINE (2019)
Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036)
Hongsheng Wang et al.
CANCER (2019)
Genomic and immune profiling of pre-invasive lung adenocarcinoma
Haiquan Chen et al.
NATURE COMMUNICATIONS (2019)
Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11
Linnea La Fleur et al.
LUNG CANCER (2019)
Mutational profile of Brazilian lung adenocarcinoma unveils association of EGFR mutations with high Asian ancestry and independent prognostic role of KRAS mutations
Leticia Ferro Leal et al.
SCIENTIFIC REPORTS (2019)
Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer
Elke J. A. H. van Beek et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Comprehensive Characterization of Cancer Driver Genes and Mutations
Matthew H. Bailey et al.
CELL (2018)
Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing
Zahra Shajani-Yi et al.
NEOPLASIA (2018)
Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients
Zahra Fathi et al.
PLOS ONE (2018)
Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center
Ville Kytola et al.
THERANOSTICS (2017)
Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations
Joshua D. Campbell et al.
JAMA ONCOLOGY (2017)
Spectrum of germline mutations in smokers and non-smokers in Brazilian non-small-cell lung cancer (NSCLC) patients
Patricia P. Couto et al.
CARCINOGENESIS (2017)
TP53 and MDM2 genetic alterations in non-small cell lung cancer: Evaluating their prognostic and predictive value
Christophe Deben et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Validation and Application of a Custom-Designed Targeted Next-Generation Sequencing Panel for the Diagnostic Mutational Profiling of Solid Tumors
Guy Froyen et al.
PLOS ONE (2016)
Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma
Matthias Preusser et al.
EUROPEAN JOURNAL OF CANCER (2015)
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Patricia A. J. Muller et al.
CANCER CELL (2014)
Whole-Genome Sequencing of Asian Lung Cancers: Second-Hand Smoke Unlikely to Be Responsible for Higher Incidence of Lung Cancer among Asian Never-Smokers
Vidhya G. Krishnan et al.
CANCER RESEARCH (2014)
TP53 Mutations and Lung Cancer: Not All Mutations Are Created Equal
Ramaswamy Govindan et al.
CLINICAL CANCER RESEARCH (2014)
Nondisruptive p53 Mutations Are Associated with Shorter Survival in Patients with Advanced Non-Small Cell Lung Cancer
Miguel A. Molina-Vila et al.
CLINICAL CANCER RESEARCH (2014)
Smoking, p53 Mutation, and Lung Cancer
Don L. Gibbons et al.
MOLECULAR CANCER RESEARCH (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Marcin Imielinski et al.
CELL (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
TP53 mutations and survival in squamous-cell carcinoma of the head and neck
M. Luana Poeta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The p53 tumor suppressor participates in multiple cell cycle checkpoints
Luciana E. Giono et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
The TP53 gene, tobacco exposure, and lung cancer
S Toyooka et al.
HUMAN MUTATION (2003)
Share Paper
